Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.
Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.
复制标题
DOI:
10.1111/j.1365-2249.2010.04176.x
复制
发表时间:
2010-08
影响因子:
4.6
通讯作者:
Lenert P
中科院分区:
文献类型:
--
作者:
Lenert P
Double-stranded (ds) DNA, DNA- or RNA-associated nucleoproteins are the primary autoimmune targets in SLE, yet their relative inability to trigger similar autoimmune responses in experimental animals has fascinated scientists for decades. While many cellular proteins non-specifically bind negatively charged nucleic acids, it was only recently discovered that several intracellular proteins are directly involved in innate recognition of exogenous DNA or RNA, or cytosol-residing DNA or RNA viruses. So, endosomal Toll-like receptors (TLR) mediate responses to double-stranded RNA (TLR3), single-stranded RNA (TLR 7/8) or unmethylated bacterial CpG-DNA (TLR9), while DAI/ZBP1, HIN-200 (p202), AIM2, RNA polymerase III, RIG-I and MDA5 mediate responses to cytosolic dsDNA or dsRNA, respectively. TLR-induced responses are more robust than those induced by cytosolic DNA- or RNA- sensors, the later usually being limited to IRF3-dependent type I IFN induction and NF-κB activation. Interestingly, AIM2 is not capable of inducing type I IFN, but rather plays a role in caspase I activation. DNA- or RNA-like synthetic oligonucleotides (INH-ODN) have been developed that antagonize TLR7- and/or TLR9-induced activation in autoimmune B cells and in type I IFN-producing dendritic cells at low nanomolar concentrations. It is not known whether these INH-ODNs have any agonistic or antagonistic effects on cytosolic DNA or RNA sensors. While this remains to be determined in the future, in vivo studies have already shown their potential for preventing spontaneous lupus in various animal models of lupus. Several groups are exploring the possibility of translating these INH-ODNs into human therapeutics for treating SLE and bacterial DNA-induced sepsis.
登录
查看更多内容
影响因子:
64.8
作者:
Alexopoulou, L;Holt, AC;Flavell, RA
通讯作者:
Flavell, RA
影响因子:
4.4
作者:
Agrawal, Hemant;Jacob, Noam;Jacob, Chaim O.
通讯作者:
Jacob, Chaim O.
影响因子:
5.4
作者:
Allam, Ramanjaneyulu;Pawar, Rahul D.;Anders, Hans-Joachim
通讯作者:
Anders, Hans-Joachim
影响因子:
30.5
作者:
通讯作者:
--
DOI:
10.1084/jem.20021553
发表时间:
2003-03-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Bennett L;Palucka AK;Arce E;Cantrell V;Borvak J;Banchereau J;Pascual V
通讯作者:
Pascual V